anterior cruciate ligament injury
Conditions
Interventions
At anterior cruciate ligament reconstruction, we will inject enamel matrix derivative (EMDOGAIN 0.3ml) between femoral and tibial bone tunnel and graft. For postoperative 2 years, we will evaluate cli
Sponsors
Hiroshima University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: the patient planed anterior cruciate ligament reconstruction the patient obtained written informed consent the patient who can visit a Hiroshima University hospital for treatment for two years
Exclusion criteria
Exclusion criteria: the patient who apply the contraindication of EMDOGAIN the patient who cannot obtaine written informed consent and had consciousness disorder or disorientation the general condition of the patient is considerably bad the patient with a serious liver damage the patient with a serious renal damage the female patient with the possibility with during the pregnancy or pregnancy the female patient under the nursing the patient with the past when is allergic to EMDOGAIN the patient who had perfomed the operation of the knee in addition, the patient who was disqualified by the chief physician for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| KT-2000 measurement of anterior knee laxity at postoperative 2 years | — |
Countries
Japan
Contacts
Public ContactKobun Takazawa
Hiroshima University Hospital Department of orthopaedic surgery
Outcome results
None listed